202604 Internal Reference | Rule "Hardening": Foreign-Funded Factory Construction, Compliance Crackdown, and Profit Re-Sorting

In April, three intersecting signals emerged in the oral industry: two European giants announced plans to establish factories in China within the same month, the Supreme People's Court and the Supreme People's Procuratorate simultaneously lowered the threshold for "relatively large amounts" in non-state employee bribery to 30,000 yuan, and profit performance during the earnings season showed clear divergence.

Ivoclar Vivadent invested $10 million in Shanghai to build an automated dental production line, while the Geistlich Group signed its first intelligent manufacturing base for oral biomaterials in Suzhou. Meanwhile, regulators designated the medical field as a target for heavier penalties, and the Medical Insurance Fund Self-Inspection and Rectification covered the oral industry for the first time, forcing companies to reassess compliance costs.

These seemingly independent developments converging at the same time suggest that the industry is undergoing a transition from "flexible rules" to "hard rules," with the competitive landscape, profit trends, and compliance strategies likely to be redefined...

This content is available to DentalGoodNews Pro members. Subscribe to read full article